Ginkgo Bioworks stock is down 37.5%, according to one Wall Street analyst.

You are reading a free article containing opinions that may differ from those of The Motley Fool’s premium investment service. Become a Motley Fool member today
Get instant access to top analyst recommendations, in-depth research, and investment resources.
And more. Learn more